|
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial
Clélia Coutzac
,
Frédéric Bibeau
,
Méher Ben Abdelghani
,
Thomas Aparicio
,
Romain Cohen
Article dans une revue
hal-03837196v1
|
|
Impact of fiducial markers placement on the delineation of target volumes in radiation therapy for oesophageal cancer: FIDUCOR study
Philippe Rochigneux
,
Marguerite Tyran
,
Aurélie Autret
,
Leonor Lopez Almeida
,
Jérôme Guiramand
Article dans une revue
hal-03869102v1
|
|
Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion
Stéphane Fattori
,
Laurent Gorvel
,
Samuel Granjeaud
,
Philippe Rochigneux
,
Marie-Sarah Rouvière
Article dans une revue
hal-03152759v1
|
|
Endoscopic Ultrasound-Guided Radiofrequency Ablation as an Future Alternative to Pancreatectomy for Pancreatic Metastases from Renal Cell Carcinoma: A Prospective Study
Brice Chanez
,
Fabrice Caillol
,
Jean-Philippe Ratone
,
Christian Pesenti
,
Philippe Rochigneux
Article dans une revue
hal-03689914v1
|
|
Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials
Philippe Rochigneux
,
Brice Chanez
,
Bernadette de Rauglaudre
,
Emmanuel Mitry
,
Christian Chabannon
Article dans une revue
hal-03689931v1
|
|
Celiac Disease After Administration of Immune Checkpoint Inhibitors: A Case Report
Julie Leblanc
,
Solene Hoibian
,
Agathe Boucraut
,
Jean-Philippe Ratone
,
Louis Stoffaes
Article dans une revue
hal-03689905v1
|
|
739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial
Renaud Sabatier
,
Cécile Vicier
,
Séverine Garnier
,
Arnaud Guille
,
Nadine Carbuccia
Article dans une revue
hal-03622737v1
|
|
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome
Anne-Sophie Chretien
,
Raynier Devillier
,
Samuel Granjeaud
,
Charlotte Cordier
,
Clemence Demerle
Proceedings of the National Academy of Sciences of the United States of America, 2021, 118 (22), pp.e2020459118. ⟨10.1073/pnas.2020459118⟩
Article dans une revue
hal-03565991v1
|
|
Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
Emilien Billon
,
Brice Chanez
,
Philippe Rochigneux
,
Laurence Albiges
,
Cécile Vicier
Article dans une revue
hal-03623028v1
|
|
Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC
Nanruoyi Zhou
,
Maria Velez
,
Benjamin Bachrach
,
Jaklin Gukasyan
,
Charlene Fares
Article dans une revue
hal-03689919v1
|
|
Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
Sandrine Rousset-Rouviere
,
Philippe Rochigneux
,
Anne-Sophie Chrétien
,
Stéphane Fattori
,
Laurent Gorvel
Article dans une revue
hal-03622756v1
|
|
Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review
Philippe Rochigneux
,
Alejandro Garcia
,
Brice Chanez
,
Anne Madroszyk
,
Daniel Olive
Article dans une revue
hal-03152719v1
|
|
Les glycosylations de PD-L1 sous les feux de la rampe
Daniel Olive
,
Anne-Sophie Chrétien
,
Raynier Devillier
,
Philippe Rochigneux
,
Laurent Gorvel
Article dans une revue
hal-02903988v1
|
|
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review
Gabrielle Planes-Laine
,
Philippe Rochigneux
,
François Bertucci
,
Anne-Sophie Chrétien
,
Patrice Viens
Article dans une revue
hal-02533030v1
|
|
Hospital end-of-life care in haematological malignancies
Yvan Beaussant
,
Etienne Daguindau
,
Adrien Chauchet
,
Philippe Rochigneux
,
Christophe Tournigand
Article dans une revue
hal-03689944v1
|
|
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review
Philippe Rochigneux
,
Jeanne Thomassin-Piana
,
Sophy Laibe
,
Serge Brunelle
,
Naji Salem
Article dans une revue
hal-04515988v1
|
|
Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors
Marjorie Faure
,
Philippe Rochigneux
,
Daniel Olive
,
Sebastien Taix
,
Isabelle Brenot-Rossi
Article dans une revue
hal-02143544v1
|
|
Acute myositis
Philippe Rochigneux
,
Nicolas Schleinitz
,
Mikael Ebbo
,
Marie Aymonier
,
Bertrand Pourroy
Article dans une revue
hal-03689955v1
|
|
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review
Philippe Rochigneux
,
Jeanne Thomassin-Piana
,
Sophy Laibe
,
Serge Brunelle
,
Naji Salem
Article dans une revue
hal-03689938v1
|
|
Timing of palliative care needs reporting and aggressiveness of care near the end of life in metastatic lung cancer: A national registry-based study
François Goldwasser
,
Pascale Vinant
,
Régis Aubry
,
Philippe Rochigneux
,
Yvan Beaussant
Article dans une revue
hal-03689951v1
|
|
Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma
P. Rochigneux
,
J. C. Nault
,
N. Ganne-Carrie
,
D. Olive
Article dans une revue
hal-02143627v1
|
|
Are lung adenocarcinoma mutations shaping the immune microenvironment?
Philippe Rochigneux
,
Edward B. Garon
Article dans une revue
hal-02143662v1
|
|
Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study
Emmanuelle Kempf
,
Christophe Tournigand
,
Philippe Rochigneux
,
Régis Aubry
,
Lucas Morin
Article dans une revue
hal-03560299v1
|
|
Gastrointestinal Stromal Tumour with Synchronous Bone Metastases: A Case Report and Literature Review
Philippe Rochigneux
,
Lénaig Mescam-Mancini
,
Delphine Perrot
,
Erwan Bories
,
Laurence Moureau-Zabotto
Article dans une revue
hal-03623722v1
|
|
Use of chemotherapy near the end of life: what factors matter?
Philippe Rochigneux
,
J.L. Raoul
,
Y. Beaussant
,
R. Aubry
,
F. Goldwasser
Article dans une revue
hal-03689961v1
|
|
Quelle vision des biomarqueurs en 2017 ? Promesses et défis de la médecine personnalisée en oncologie
Ronan Flippot
,
Christophe Massard
,
Édouard Auclin
,
David Azria
,
Heloise Bourien
Article dans une revue
hal-02370054v1
|
|
Les actualités marquantes du congrès Targeted Anticancer Therapies — TAT 2016
R. Flippot
,
I. Bouallagui
,
P. Du Rusquec
,
P. Gougis
,
C. Henon
Article dans une revue
hal-03689977v1
|
|
End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study
I. Gallais Sérézal
,
Y. Beaussant
,
Philippe Rochigneux
,
C. Tournigand
,
R. Aubry
Article dans une revue
hal-03689969v1
|